Under current standards, when is an impairment loss reported on a significant influence investment in the stock of another company, following U.S. GAAP and IFR?
A) U.S. GAAP: Carrying value exceeds fair value, and the decline is other than temporary. IFRS: Carrying value is greater than the higher of market value or value-in-use, and a loss event has occurred.
B) U.S. GAAP: Book value is greater than the higher of market value or value-in-use, and the decline is other than temporary. IFRS: Carrying value exceeds fair value, and the decline is other than temporary.
C) U.S. GAAP: Not reported IFRS: Carrying value is greater than the higher of market value or value-in-use, and a loss event has occurred.
D) U.S. GAAP: Carrying value is greater than the higher of market value or value-in-use, and a loss event has occurred. IFRS: Not reported
Correct Answer:
Verified
Q68: Sanofi reports using IFRS and invests in
Q69: At the beginning of the current year,
Q70: IFRS requires joint ventures to be reported
Q71: Unless there is a "significant deterioration" in
Q72: What is "value-in-use," as used in reporting
Q74: Under IFRS 9, IFRS companies can choose
Q75: Under IFRS 9, IFRS companies can choose
Q76: Realized gains and losses on which of
Q77: IFRS 9 identifies what categories of investments
Q78: Following IFRS, significant influence investments are usually
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents